Cerner Corp
LSE:0R00
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Chevron Corp
NYSE:CVX
|
Energy
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
N/A
N/A
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Walmart Inc
NYSE:WMT
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.
Intrinsic Value
There is not enough data to reliably calculate the intrinsic value of 0R00.
The Intrinsic Value is calculated as the average of DCF and Relative values:
| US |
|
Veeva Systems Inc
NYSE:VEEV
|
|
| AU |
|
Pro Medicus Ltd
ASX:PME
|
|
| JP |
|
M3 Inc
TSE:2413
|
|
| US |
|
Doximity Inc
NYSE:DOCS
|
|
| US |
W
|
Waystar Holding Corp
NASDAQ:WAY
|
|
| SE |
|
Sectra AB
STO:SECT B
|
|
| US |
|
Inspire Medical Systems Inc
NYSE:INSP
|
|
| IN |
I
|
Inventurus Knowledge Solutions Ltd
NSE:IKS
|
|
| US |
V
|
Vocera Communications Inc
F:V00
|
|
| CN |
|
Winning Health Technology Group Co Ltd
SZSE:300253
|
Fundamental Analysis
Select up to 3 indicators:
Select up to 3 indicators:
Cerner’s integration under Oracle’s umbrella faces potential execution challenges, risking prolonged margin pressure and cost overruns that could erode profitability.
Heightened competition from newer, more agile EHR providers and established rivals like Epic threatens Cerner’s market share and may force price concessions, squeezing margins.
Shifting regulatory requirements and complex implementation processes for hospital systems could elongate sales cycles and curtail revenue growth in the near term.
Cerner’s entrenched relationships with large U.S. health systems and proven EHR solutions create strong recurring revenue streams and high switching costs.
Expansion into value-added services like data analytics and population health positions Cerner for higher-margin growth opportunities beyond basic medical record management.
Potential synergies from Oracle’s cloud platform could accelerate innovation in Cerner’s software solutions, enhancing differentiation and long-term profitability.
Revenue & Expenses Breakdown
Cerner Corp
Balance Sheet Decomposition
Cerner Corp
| Current Assets | 2.5B |
| Cash & Short-Term Investments | 880.7m |
| Receivables | 1.2B |
| Other Current Assets | 409.1m |
| Non-Current Assets | 4.9B |
| Long-Term Investments | 456.4m |
| PP&E | 1.7B |
| Intangibles | 1.4B |
| Other Non-Current Assets | 1.3B |
| Current Liabilities | 1.4B |
| Accounts Payable | 359.6m |
| Accrued Liabilities | 284.1m |
| Other Current Liabilities | 735.2m |
| Non-Current Liabilities | 2.1B |
| Long-Term Debt | 1.6B |
| Other Non-Current Liabilities | 475.5m |
Free Cash Flow Analysis
Cerner Corp
| USD | |
| Free Cash Flow | USD |
Earnings Waterfall
Cerner Corp
|
Revenue
|
5.8B
USD
|
|
Cost of Revenue
|
-1B
USD
|
|
Gross Profit
|
4.8B
USD
|
|
Operating Expenses
|
-4.1B
USD
|
|
Operating Income
|
742.2m
USD
|
|
Other Expenses
|
-152.7m
USD
|
|
Net Income
|
589.5m
USD
|
0R00 Profitability Score
Profitability Due Diligence
Cerner Corp's profitability score is 54/100. The higher the profitability score, the more profitable the company is.
Score
Cerner Corp's profitability score is 54/100. The higher the profitability score, the more profitable the company is.
0R00 Solvency Score
Solvency Due Diligence
Cerner Corp's solvency score is 73/100. The higher the solvency score, the more solvent the company is.
Score
Cerner Corp's solvency score is 73/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
0R00 Price Targets Summary
Cerner Corp
Dividends
Current shareholder yield for 0R00 is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?